You don't have permission to view this recording. Please log in or use your personalized link.
Recorded
Tuesday, 17/10/2023 · 14:00
DESTINY PHARMA PLC - XF product pipeline
Recorded
Tuesday, 17/10/2023 · 14:00
ABOUT THIS WEBINAR
Investor Meet Company is a digital platform, that provides individual investors direct access to UK Listed companies for live, interactive management presentations.
ADDITIONAL INFO
When:
Tuesday, 17/10/2023 · 14:00
London
Duration: 3 hours
Price:Free
Language:English
Who can attend?Anyone with the event link can attend
Dial-in available?
(listen only):Yes.
Dial-in Number:
Please register for this Webinar to view the dial-in info.
Dr. Mericli is an Associate Professor of Plastic Surgery at The University of Texas MD Anderson Cancer Center. He completed his plastic surgery residency at the University of Virginia, followed by a fellowship in microvascular and reconstructive...
Chris is a highly experienced, senior pharmaceutical executive. He was most recently COO, Executive Vice President, and Managing Director of Europe and International at Jazz Pharmaceuticals following the acquisition of GW Pharmaceuticals (GW),...
Dr Love was a senior scientist at Ciba Geigy/Novartis focused on novel drug delivery technologies and involved in the development of the world’s leading eye-care pharmaceutical, Visudyne. In 1997, Dr Love founded Destiny Pharma and he is the...
Dr Martina is a Medical Doctor with a PhD in Genetics and Molecular Biology, an MBA and a Master’s in Project Management. He has more than 20 years’ experience in clinical development working with key regulatory, industry and government...
Richard A Proctor, MD is the Professor Emeritus of Department of Medical Microbiology/Immunology and Professor Emeritus of Department of Medicine at University of Wisconsin School of Medicine and Public Health Madison, Wisconsin. He also served as...